Cargando…
Casein Kinase 2α Regulates Glioblastoma Brain Tumor Initiating Cell Growth through the β-Catenin Pathway
Glioblastoma (GBM) is the most common and fatal primary brain tumor in humans and it is essential that new and better therapies are developed to treat this disease. Previous research suggests that casein kinase 2 (CK2), may be a promising therapeutic target for GBMs. CK2 has enhanced expression or a...
Autores principales: | Nitta, Ryan T., Gholamin, Sharareh, Feroze, Abdullah H., Agarwal, Maya, Cheshier, Samuel H., Mitra, Siddhartha S., Li, Gordon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4369469/ https://www.ncbi.nlm.nih.gov/pubmed/25241897 http://dx.doi.org/10.1038/onc.2014.299 |
Ejemplares similares
-
γ-Glutamyl transferase 7 is a novel regulator of glioblastoma growth
por: Bui, Timothy T, et al.
Publicado: (2015) -
Irradiation or temozolomide chemotherapy enhances anti-CD47 treatment of glioblastoma
por: Gholamin, Sharareh, et al.
Publicado: (2019) -
Microglia are effector cells of CD47-SIRPα antiphagocytic axis disruption against glioblastoma
por: Hutter, Gregor, et al.
Publicado: (2019) -
The anti‐hypertensive drug prazosin inhibits glioblastoma growth via the PKCδ‐dependent inhibition of the AKT pathway
por: Assad Kahn, Suzana, et al.
Publicado: (2016) -
Roles of PINK1, mTORC2, and mitochondria in preserving brain tumor-forming stem cells in a noncanonical Notch signaling pathway
por: Lee, Kyu-Sun, et al.
Publicado: (2013)